SCHEMBL4648476

SCHEMBL4648476

O=C(Cl)C(=O)Oc1c[nH]c2ccccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 2/20 0.66
PBRM1 Q86U86 1/20 0.49
GPR84 Q9NQS5 1/20 0.47
NR4A2 P43354 2/20 0.46
CREBBP Q92793 1/20 0.45
ALDH1A1 P00352 3/20 0.45
ATM Q13315 1/20 0.45
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
MAPK1 P28482 1/20 0.41
KDM4E B2RXH2 2/20 0.41
APAF1 O14727 1/20 0.41
POLB P06746 1/20 0.41
RECQL P46063 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MPO P05164 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2704556 0.90 SLC22A6 (0.74) SLC22A6PBRM1GPR84NR4A2CREBBP
SCHEMBL6261233 0.86 SLC22A6 (0.70) SLC22A6PBRM1GPR84NR4A2CREBBP
SCHEMBL9047908 0.85 SLC22A6 (0.68) SLC22A6PBRM1GPR84NR4A2CREBBP
SCHEMBL125250 0.83 SLC22A6 (0.76) SLC22A6PBRM1GPR84NR4A2CREBBP
SCHEMBL27729377 0.82 SLC22A6 (0.74) SLC22A6PBRM1GPR84NR4A2CREBBP
SCHEMBL11042304 0.82 SLC22A6 (0.73) SLC22A6PBRM1GPR84NR4A2CREBBP
SCHEMBL23295617 0.81 SLC22A6 (0.72) SLC22A6PBRM1GPR84NR4A2CREBBP
SCHEMBL1831734 0.81 SLC22A6 (0.72) SLC22A6PBRM1GPR84NR4A2CREBBP
SCHEMBL2001612 0.80 SLC22A6 (0.65) SLC22A6PBRM1GPR84NR4A2CREBBP
SCHEMBL28768822 0.79 SLC22A6 (0.70) SLC22A6PBRM1GPR84NR4A2CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111349088-B Indole-based heterocyclic compounds, preparation method thereof and application thereof in controlling plant diseases 天津师范大学 2022-09-20 CN claimed
CN-111349088-A Indole-based heterocyclic compounds, preparation method thereof and application thereof in controlling plant diseases 天津师范大学 2020-06-30 CN claimed
CN-111349089-A Indole heterocyclic compound, preparation method thereof and application thereof in preventing and treating plant diseases 天津师范大学 2020-06-30 CN claimed
CN-111349089-B Indole heterocyclic compounds, preparation method thereof and application thereof in preventing and treating plant diseases 天津师范大学 2022-11-29 CN disclosed
CN-111349089-B Indole heterocyclic compounds, preparation method thereof and application thereof in preventing and treating plant diseases 天津师范大学 2022-11-29 CN disclosed
CN-111349088-B Indole-based heterocyclic compounds, preparation method thereof and application thereof in controlling plant diseases 天津师范大学 2022-09-20 CN disclosed
CN-111349088-B Indole-based heterocyclic compounds, preparation method thereof and application thereof in controlling plant diseases 天津师范大学 2022-09-20 CN disclosed
CN-111349088-A Indole-based heterocyclic compounds, preparation method thereof and application thereof in controlling plant diseases 天津师范大学 2020-06-30 CN disclosed
CN-111349088-A Indole-based heterocyclic compounds, preparation method thereof and application thereof in controlling plant diseases 天津师范大学 2020-06-30 CN disclosed
CN-111349089-A Indole heterocyclic compound, preparation method thereof and application thereof in preventing and treating plant diseases 天津师范大学 2020-06-30 CN disclosed
CN-111349089-A Indole heterocyclic compound, preparation method thereof and application thereof in preventing and treating plant diseases 天津师范大学 2020-06-30 CN disclosed
CN-101312722-A Modulators of atp-binding cassette transporters VERTEX PHARMA (US) 2008-11-26 CN disclosed
EP-1675830-A4 HETEROCYCLIC AMIDES AND SULFONAMIDES SCIOS INC (US) 2008-08-20 EP disclosed
US-20060199821-A1 Heterocyclic amides and sulfonamides SCIOS, INC. (US) 2006-09-07 US disclosed
EP-1675830-A2 HETEROCYCLIC AMIDES AND SULFONAMIDES SCIOS INC. (US) 2006-07-05 EP disclosed
WO-2005033072-A2 HETEROCYCLIC AMIDES AND SULFONAMIDES SCIOS INC. (US) 2005-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060199821-A1 Heterocyclic amides and sulfonamides MAP4K2, MAP3K8, MAP3K2 SLC22A6 3388/4885PBRM1 2963/4885GPR84 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.